BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Theuerkorn M, Fischer G, Schiene-fischer C. Prolyl cis/trans isomerase signalling pathways in cancer. Current Opinion in Pharmacology 2011;11:281-7. [DOI: 10.1016/j.coph.2011.03.007] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Velazquez HA, Hamelberg D. Conformation-Directed Catalysis and Coupled Enzyme–Substrate Dynamics in Pin1 Phosphorylation-Dependent Cis–Trans Isomerase. J Phys Chem B 2013;117:11509-17. [DOI: 10.1021/jp405271s] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
2 Zhou XZ, Lu KP. The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target. Nat Rev Cancer. 2016;16:463-478. [PMID: 27256007 DOI: 10.1038/nrc.2016.49] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 20.2] [Reference Citation Analysis]
3 Daneri-becerra C, Patiño-gaillez MG, Galigniana MD. Proof that the high molecular weight immunophilin FKBP52 mediates the in vivo neuroregenerative effect of the macrolide FK506. Biochemical Pharmacology 2020;182:114204. [DOI: 10.1016/j.bcp.2020.114204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Xu N, Tochio N, Wang J, Tamari Y, Uewaki J, Utsunomiya-Tate N, Igarashi K, Shiraki T, Kobayashi N, Tate S. The C113D mutation in human Pin1 causes allosteric structural changes in the phosphate binding pocket of the PPIase domain through the tug of war in the dual-histidine motif. Biochemistry 2014;53:5568-78. [PMID: 25100325 DOI: 10.1021/bi5007817] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
5 Nagaraju M, Mcgowan LC, Hamelberg D. Cyclophilin A Inhibition: Targeting Transition-State-Bound Enzyme Conformations for Structure-Based Drug Design. J Chem Inf Model 2013;53:403-10. [DOI: 10.1021/ci300432w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
6 Barman A, Hamelberg D. Coupled Dynamics and Entropic Contribution to the Allosteric Mechanism of Pin1. J Phys Chem B 2016;120:8405-15. [DOI: 10.1021/acs.jpcb.6b02123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
7 Dunyak BM, Gestwicki JE. Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds. J Med Chem 2016;59:9622-44. [PMID: 27409354 DOI: 10.1021/acs.jmedchem.6b00411] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
8 Vivoli M, Renou J, Chevalier A, Norville IH, Diaz S, Juli C, Atkins H, Holzgrabe U, Renard PY, Sarkar-Tyson M, Harmer NJ. A miniaturized peptidyl-prolyl isomerase enzyme assay. Anal Biochem 2017;536:59-68. [PMID: 28803887 DOI: 10.1016/j.ab.2017.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Barman A, Smitherman C, Souffrant M, Gadda G, Hamelberg D. Conserved Hydration Sites in Pin1 Reveal a Distinctive Water Recognition Motif in Proteins. J Chem Inf Model 2016;56:139-47. [DOI: 10.1021/acs.jcim.5b00560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Zgajnar NR, De Leo SA, Lotufo CM, Erlejman AG, Piwien-Pilipuk G, Galigniana MD. Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52. Biomolecules 2019;9:E52. [PMID: 30717249 DOI: 10.3390/biom9020052] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
11 Cheng F, Yuan W, Cao M, Chen R, Wu X, Yan J. Cyclophilin A Protects Cardiomyocytes against Hypoxia/Reoxygenation-Induced Apoptosis via the AKT/Nox2 Pathway. Oxid Med Cell Longev 2019;2019:2717986. [PMID: 31182989 DOI: 10.1155/2019/2717986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
12 Atencio D, Barnes C, Duncan TM, Willis IM, Hanes SD. The yeast Ess1 prolyl isomerase controls Swi6 and Whi5 nuclear localization. G3 (Bethesda) 2014;4:523-37. [PMID: 24470217 DOI: 10.1534/g3.113.008763] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
13 Mori T, Saito S. Conformational Excitation and Nonequilibrium Transition Facilitate Enzymatic Reactions: Application to Pin1 Peptidyl-Prolyl Isomerase. J Phys Chem Lett 2019;10:474-80. [PMID: 30607953 DOI: 10.1021/acs.jpclett.8b03607] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
14 Ulagesan S, Choi JW, Nam TJ, Choi YH. Peptidyl-prolyl isomerase and the biological activities of recombinant protein cyclophilin from Pyropia yezoensis (PyCyp). Protein Expr Purif 2020;172:105636. [PMID: 32272150 DOI: 10.1016/j.pep.2020.105636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Li K, Ma T, Cai J, Huang M, Guo H, Zhou D, Luan S, Yang J, Liu D, Jing Y, Zhao L. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability. Bioorganic & Medicinal Chemistry 2017;25:5441-51. [DOI: 10.1016/j.bmc.2017.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
16 Gholamzadeh Khoei S, Saidijam M, Amini R, Jalali A, Najafi R. Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer. J Gastrointest Cancer 2021. [PMID: 33580870 DOI: 10.1007/s12029-021-00600-6] [Reference Citation Analysis]
17 Vo DK, Engler A, Stoimenovski D, Hartig R, Kaehne T, Kalinski T, Naumann M, Haybaeck J, Nass N. Interactome Mapping of eIF3A in a Colon Cancer and an Immortalized Embryonic Cell Line Using Proximity-Dependent Biotin Identification. Cancers (Basel) 2021;13:1293. [PMID: 33799492 DOI: 10.3390/cancers13061293] [Reference Citation Analysis]
18 Ladani ST, Souffrant MG, Barman A, Hamelberg D. Computational perspective and evaluation of plausible catalytic mechanisms of peptidyl-prolyl cis-trans isomerases. Biochim Biophys Acta 2015;1850:1994-2004. [PMID: 25585011 DOI: 10.1016/j.bbagen.2014.12.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
19 Rodriguez‐bussey IG, Doshi U, Hamelberg D, Mccammon J. Enhanced molecular dynamics sampling of drug target conformations. Biopolymers 2016;105:35-42. [DOI: 10.1002/bip.22740] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
20 Moritsugu K, Yamamoto N, Yonezawa Y, Tate SI, Fujisaki H. Path Ensembles for Pin1-Catalyzed Cis-Trans Isomerization of a Substrate Calculated by Weighted Ensemble Simulations. J Chem Theory Comput 2021;17:2522-9. [PMID: 33769826 DOI: 10.1021/acs.jctc.0c01280] [Reference Citation Analysis]
21 Costantino S, Paneni F, Lüscher TF, Cosentino F. Pin1 inhibitor Juglone prevents diabetic vascular dysfunction. International Journal of Cardiology 2016;203:702-7. [DOI: 10.1016/j.ijcard.2015.10.221] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
22 Fasseas MK, Dimou M, Katinakis P. The Caenorhabditis elegans parvulin gene subfamily and their expression under cold or heat stress along with the fkb subfamily. Biochem Biophys Res Commun 2012;423:520-5. [PMID: 22683625 DOI: 10.1016/j.bbrc.2012.05.157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
23 Polonio-Vallon T, Krüger D, Hofmann TG. ShaPINg Cell Fate Upon DNA Damage: Role of Pin1 Isomerase in DNA Damage-Induced Cell Death and Repair. Front Oncol 2014;4:148. [PMID: 24982848 DOI: 10.3389/fonc.2014.00148] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
24 Zhu GF, Lyu SL, Liu Y, Ma C, Wang W. Spectroscopic and computational studies on the binding interaction between gallic acid and Pin1. Luminescence 2021. [PMID: 34490991 DOI: 10.1002/bio.4138] [Reference Citation Analysis]
25 Wu K, Zhong H, Yang G, Wu C, Huang J, Li G, Ma D, Leung C. Small Molecule Pin1 Inhibitor Blocking NF-κB Signaling in Prostate Cancer Cells. Chem Asian J 2018;13:275-9. [DOI: 10.1002/asia.201701216] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
26 Schrama D, Hesbacher S, Angermeyer S, Schlosser A, Haferkamp S, Aue A, Adam C, Weber A, Schmidt M, Houben R. Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cells. Int J Cancer 2016;138:1153-62. [PMID: 26383606 DOI: 10.1002/ijc.29862] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hong C, Li T, Zhang F, Wu X, Chen X, Cui X, Zhang G, Cui Y. Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer. Oncol Lett 2017;14:5379-85. [PMID: 29113172 DOI: 10.3892/ol.2017.6828] [Reference Citation Analysis]
28 Marsolier J, Weitzman JB. Pin1 : une peptidyl-prolyl cis-trans isomérase multifonctionnelle et une cible anticancéreuse prometteuse. Med Sci (Paris) 2014;30:772-8. [DOI: 10.1051/medsci/20143008015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Velazquez HA, Hamelberg D. Dynamical role of phosphorylation on serine/threonine-proline Pin1 substrates from constant force molecular dynamics simulations. The Journal of Chemical Physics 2015;142:075102. [DOI: 10.1063/1.4907884] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
30 Bouallegui Y, Ben Younes R, Oueslati R, Sheehan D. Redox proteomic insights into involvement of clathrin-mediated endocytosis in silver nanoparticles toxicity to Mytilus galloprovincialis. PLoS One 2018;13:e0205765. [PMID: 30372447 DOI: 10.1371/journal.pone.0205765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Nakamura K, Greenwood A, Binder L, Bigio EH, Denial S, Nicholson L, Zhou XZ, Lu KP. Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. Cell 2012;149:232-44. [PMID: 22464332 DOI: 10.1016/j.cell.2012.02.016] [Cited by in Crossref: 159] [Cited by in F6Publishing: 149] [Article Influence: 15.9] [Reference Citation Analysis]
32 Rodriguez-bussey I, Yao X, Shouaib AD, Lopez J, Hamelberg D. Decoding Allosteric Communication Pathways in Cyclophilin A with a Comparative Analysis of Perturbed Conformational Ensembles. J Phys Chem B 2018;122:6528-35. [DOI: 10.1021/acs.jpcb.8b03824] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
33 Friedman R, Boye K, Flatmark K. Molecular modelling and simulations in cancer research. Biochim Biophys Acta 2013;1836:1-14. [PMID: 23416097 DOI: 10.1016/j.bbcan.2013.02.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
34 Keune W, Jones DR, Divecha N. PtdIns5P and Pin1 in oxidative stress signaling. Advances in Biological Regulation 2013;53:179-89. [DOI: 10.1016/j.jbior.2013.02.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
35 Li X, Li L, Zhou Q, Zhang N, Zhang S, Zhao R, Liu D, Jing Y, Zhao L. Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors. Bioorg Med Chem Lett. 2014;24:5612-5615. [PMID: 25466185 DOI: 10.1016/j.bmcl.2014.10.087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
36 Pu W, Zheng Y, Peng Y. Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance. Front Cell Dev Biol 2020;8:168. [PMID: 32296699 DOI: 10.3389/fcell.2020.00168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Feitelson MA, Bonamassa B, Arzumanyan A. The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease. Expert Opin Ther Targets. 2014;18:293-306. [PMID: 24387282 DOI: 10.1517/14728222.2014.867947] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
38 Wang J, Kawasaki R, Uewaki JI, Rashid AUR, Tochio N, Tate SI. Dynamic Allostery Modulates Catalytic Activity by Modifying the Hydrogen Bonding Network in the Catalytic Site of Human Pin1. Molecules 2017;22:E992. [PMID: 28617332 DOI: 10.3390/molecules22060992] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
39 Velazquez HA, Hamelberg D. Conformational Selection in the Recognition of Phosphorylated Substrates by the Catalytic Domain of Human Pin1. Biochemistry 2011;50:9605-15. [DOI: 10.1021/bi2009954] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
40 Zhang J, Chen M, Zhu Y, Dai X, Dang F, Ren J, Ren S, Shulga YV, Beca F, Gan W, Wu F, Lin YM, Zhou X, DeCaprio JA, Beck AH, Lu KP, Huang J, Zhao C, Sun Y, Gao X, Pandolfi PP, Wei W. SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression. Dev Cell 2019;48:329-344.e5. [PMID: 30595538 DOI: 10.1016/j.devcel.2018.11.035] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
41 Barman A, Hamelberg D. Cysteine-mediated dynamic hydrogen-bonding network in the active site of Pin1. Biochemistry 2014;53:3839-50. [PMID: 24840168 DOI: 10.1021/bi5000977] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
42 Ueberham U, Rohn S, Ueberham E, Wodischeck S, Hilbrich I, Holzer M, Brückner MK, Gruschka H, Arendt T. Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease. Neuropathol Appl Neurobiol 2014;40:815-32. [PMID: 24964035 DOI: 10.1111/nan.12163] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
43 Bannon JH, O'Donovan DS, Kennelly SM, Mc Gee MM. The peptidyl prolyl isomerase cyclophilin A localizes at the centrosome and the midbody and is required for cytokinesis. Cell Cycle 2012;11:1340-53. [PMID: 22421161 DOI: 10.4161/cc.19711] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
44 Romano S, D'Angelillo A, Romano MF. Pleiotropic roles in cancer biology for multifaceted proteins FKBPs. Biochim Biophys Acta 2015;1850:2061-8. [PMID: 25592270 DOI: 10.1016/j.bbagen.2015.01.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
45 Ciarapica R, Methot L, Tang Y, Lo R, Dali R, Buscarlet M, Locatelli F, del Sal G, Rota R, Stifani S. Prolyl isomerase Pin1 and protein kinase HIPK2 cooperate to promote cortical neurogenesis by suppressing Groucho/TLE:Hes1-mediated inhibition of neuronal differentiation. Cell Death Differ 2014;21:321-32. [PMID: 24270405 DOI: 10.1038/cdd.2013.160] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
46 Kovermann M, Schmid FX, Balbach J. Molecular function of the prolyl cis/trans isomerase and metallochaperone SlyD. Biol Chem 2013;394:965-75. [PMID: 23585180 DOI: 10.1515/hsz-2013-0137] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
47 Wear MA, Nowicki MW, Blackburn EA, McNae IW, Walkinshaw MD. Thermo-kinetic analysis space expansion for cyclophilin-ligand interactions - identification of a new nonpeptide inhibitor using Biacore™ T200. FEBS Open Bio 2017;7:533-49. [PMID: 28396838 DOI: 10.1002/2211-5463.12201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Rocchetti F, Tran Quang C, Maragno AL, Nguyen J, Lasgi C, Ghysdael J. The calcineurin protein phosphatase is dispensable for BCR-ABL-induced B-ALL maintenance, propagation and response to dasatinib. Leukemia 2017;31:248-51. [PMID: 27694923 DOI: 10.1038/leu.2016.269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Yao X, Momin M, Hamelberg D. Elucidating Allosteric Communications in Proteins with Difference Contact Network Analysis. J Chem Inf Model 2018;58:1325-30. [DOI: 10.1021/acs.jcim.8b00250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
50 Ma Z, Atencio D, Barnes C, DeFiglio H, Hanes SD. Multiple roles for the Ess1 prolyl isomerase in the RNA polymerase II transcription cycle. Mol Cell Biol 2012;32:3594-607. [PMID: 22778132 DOI: 10.1128/MCB.00672-12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
51 Moore JD, Potter A. Pin1 inhibitors: Pitfalls, progress and cellular pharmacology. Bioorg Med Chem Lett. 2013;23:4283-4291. [PMID: 23796453 DOI: 10.1016/j.bmcl.2013.05.088] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
52 Wu KJ, Liu X, Wong SY, Zhou Y, Ma DL, Leung CH. Synthesis and Evaluation of Dibenzothiophene Analogues as Pin1 Inhibitors for Cervical Cancer Therapy. ACS Omega 2019;4:9228-34. [PMID: 31460012 DOI: 10.1021/acsomega.9b00281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
53 Satoh K, Godo S, Saito H, Enkhjargal B, Shimokawa H. Dual roles of vascular-derived reactive oxygen species--with a special reference to hydrogen peroxide and cyclophilin A. J Mol Cell Cardiol 2014;73:50-6. [PMID: 24406688 DOI: 10.1016/j.yjmcc.2013.12.022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
54 Wang J, Tochio N, Kawasaki R, Tamari Y, Xu N, Uewaki J, Utsunomiya-Tate N, Tate S. Allosteric Breakage of the Hydrogen Bond within the Dual-Histidine Motif in the Active Site of Human Pin1 PPIase. Biochemistry 2015;54:5242-53. [PMID: 26226559 DOI: 10.1021/acs.biochem.5b00606] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
55 Bahmed K, Henry C, Holliday M, Redzic J, Ciobanu M, Zhang F, Weekes C, Sclafani R, Degregori J, Eisenmesser E. Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B. Cancer Cell Int 2012;12:19. [PMID: 22631225 DOI: 10.1186/1475-2867-12-19] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
56 Barge S, Jade D, Ayyamperumal S, Manna P, Borah J, Nanjan CMJ, Nanjan MJ, Talukdar NC. Potential inhibitors for FKBP51: an in silico study using virtual screening, molecular docking and molecular dynamics simulation. J Biomol Struct Dyn 2021;:1-13. [PMID: 34709133 DOI: 10.1080/07391102.2021.1994877] [Reference Citation Analysis]
57 Skagia A, Zografou C, Venieraki A, Fasseas C, Katinakis P, Dimou M. Functional analysis of the cyclophilin PpiB role in bacterial cell division. Genes Cells 2017;22:810-24. [DOI: 10.1111/gtc.12514] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
58 Kahlert V, Prell E, Ohlenschläger O, Melesina J, Schumann M, Lücke C, Fischer G, Malešević M. Synthesis and biochemical evaluation of two novel N -hydroxyalkylated cyclosporin A analogs. Org Biomol Chem 2018;16:4338-49. [DOI: 10.1039/c8ob00980e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Wang M, Ferreira RB, Law ME, Davis BJ, Yaaghubi E, Ghilardi AF, Sharma A, Avery BA, Rodriguez E, Chiang CW, Narayan S, Heldermon CD, Castellano RK, Law BK. A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers. Oncogene 2019;38:4264-82. [PMID: 30718919 DOI: 10.1038/s41388-019-0717-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Denic M, Turlin E, Michel V, Fischer F, Khorasani-Motlagh M, Zamble D, Vinella D, de Reuse H. A novel mode of control of nickel uptake by a multifunctional metallochaperone. PLoS Pathog 2021;17:e1009193. [PMID: 33444370 DOI: 10.1371/journal.ppat.1009193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
61 Nguyen TA, Menendez D, Resnick MA, Anderson CW. Mutant TP53 posttranslational modifications: challenges and opportunities. Hum Mutat 2014;35:738-55. [PMID: 24395704 DOI: 10.1002/humu.22506] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
62 Mori T, Saito S. Dissecting the Dynamics during Enzyme Catalysis: A Case Study of Pin1 Peptidyl-Prolyl Isomerase. J Chem Theory Comput 2020;16:3396-407. [PMID: 32268066 DOI: 10.1021/acs.jctc.9b01279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Schumann M, Ihling CH, Prell E, Schierhorn A, Sinz A, Fischer G, Schiene-Fischer C, Malešević M. Identification of low abundance cyclophilins in human plasma. Proteomics 2016;16:2815-26. [PMID: 27586231 DOI: 10.1002/pmic.201600221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
64 Brichkina A, Nguyen NT, Baskar R, Wee S, Gunaratne J, Robinson RC, Bulavin DV. Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions. Cell Death Differ 2016;23:1592-601. [PMID: 27233083 DOI: 10.1038/cdd.2016.45] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]